The availability of an anticoagulant reversal agent in Australia has changed the conversation about treatment choices for patients and removed a concern for clinicians, a cardiologist says. Speaking to the limbic following a breakfast symposium, held at the recent Cardiology Society of Australia and New Zealand annual conference in Adelaide, Professor John Amerena a cardiologist ...
How an anticoagulant reversal agent is changing the treatment conversation
8 Sep 2016
Sponsored by Boehringer Ingelheim Pty Ltd